Mobile Health Exercise Program for Cancer Survivors
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether a mobile health program, using a fitness tracker and an app, can help cancer survivors stay active and improve their quality of life. Participants will receive either just the fitness tracker or both the tracker and a personalized exercise app (mHealth/sFitRx). The trial seeks cancer survivors who completed treatment at least three months ago and are not currently in any other health programs. Participants should own a smartphone and be open to trying a new exercise method. As an unphased trial, this study offers a unique opportunity to explore innovative ways to enhance well-being after cancer treatment.
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications. However, it does allow continued maintenance immunotherapy or endocrine therapy.
What prior data suggests that this m-health intervention is safe for cancer survivors?
Research shows that mobile health programs, like the one under testing, are generally safe and easy to use. Previous studies with similar tools have shown good results without major safety issues. For instance, one study found that cancer survivors using a similar mobile health program increased their daily steps without negative effects. These apps have also effectively tracked symptoms and health status, with many participants using them regularly. Although this trial doesn't involve direct medical treatment, the technology has a strong safety record in related studies.12345
Why are researchers excited about this trial?
Researchers are excited about the Mobile Health Exercise Program because it leverages modern technology to aid cancer survivors in maintaining physical activity. Unlike traditional rehabilitation programs that often require in-person visits, this program uses a personalized mobile health (mHealth) application called sFitRx, which delivers custom exercise plans right to a participant's smartphone. Coupled with a fitness tracker, it allows users to monitor their activity levels in real-time, making it more engaging and accessible. This innovative approach aims to empower cancer survivors by providing convenient, on-the-go support, potentially leading to better adherence and improved health outcomes compared to conventional methods.
What evidence suggests that this mHealth program is effective for cancer survivors?
Research has shown that mobile health (mHealth) exercise programs, such as the sFitRx app, can improve fitness in cancer survivors. In this trial, participants in the Experimental Group will receive access to the sFitRx app, which provides personalized physical activity programming, along with a fitness tracker to monitor activity levels. One review found that these programs lead to small-to-moderate improvements in heart and lung fitness. Another study demonstrated that personalized exercise plans through mHealth increased the number of daily steps taken by cancer survivors. These findings suggest that using a fitness app with a tracker might help those in recovery become more active and healthier. Participants in the Comparison Group will receive only the fitness tracker.35678
Are You a Good Fit for This Trial?
This trial is for cancer survivors leading a sedentary lifestyle who are interested in improving their physical activity and health outcomes. Participants should be comfortable using mobile health technology like fitness trackers.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a personalized mHealth intervention via a fitness wearable and exercise app for 12 months
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- mHealth/sFitRx
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Tennessee, Knoxville
Lead Sponsor
University of Tennessee Medical Center
Collaborator
University of Tennessee
Collaborator